The aA-crystallin promoter was used to target expression of bone morphogenetic protein 7 (BMP7) to lens fiber cells in transgenic mice. Surprisingly, lens-specific expression of BMP7 induced widespread apoptosis and rapid ablation of the neural retina in multiple families. Subsequent to retinal ablation, the lens bow region shifted posteriorly until lens epithelial cells completely enveloped the lens. Lens-specific expression of FGF3 was found to rescue the loss of fiber cell differentiation. Our results show that elevated BMP7 levels can induce rapid retinal degeneration accompanied by disruption of the endogenous ocular system for fiber cell induction. Ó
Introduction
Lens formation is a classic example of embryonic induction (Graw, 1996; Wride, 1996) . During early eye development, the optic vesicle (which later differentiates into the retina) is needed for lens placode formation. Bone morphogenetic proteins (BMPs), secreted proteins belonging to the TGF-b superfamily, appear to be necessary for the initial morphogenetic events of lens formation (Dudley, Lyons, & Robertson, 1995; Luo et al., 1995; Furuta & Hogan, 1998; Wawersik et al., 1999) . Following lens induction, the lens placode invaginates, forms a hollow lens vesicle, and receives a differentiation signal from the vitreous that converts the posterior lens epithelial cells into primary fiber cells. Lens epithelial cells facing the aqueous humor continue to proliferate and consequently are displaced toward the lens equator where they encounter the lens fiber differentiation signal(s) and are induced to form secondary fiber cells (McAvoy, Chamberlain, de Iongh, Hales, & Lovicu, 1999) .
Studies suggest that the retina provides the differentiation signal(s). When chicken lenses were rotated 180°, the epithelial cells facing the vitreous humor began to differentiate while the fiber cells facing the aqueous humor stopped elongating (Coulombre & Coulombre, 1963) . Surgical removal of the retina from the frog (Sokolova, Farberov, & Popov, 1970) and mouse (Yamamoto, 1976) resulted in loss of lens fiber differentiation. Furthermore, treatment of rat lens epithelial cell explants with retinal extracts caused the lens cells to elongate and to express markers for differentiated lens fiber cells (McAvoy & Fernon, 1984) .
To investigate possible roles of BMPs in ocular signaling after lens induction, transgenic mice expressing BMP7 specifically in the lens were generated. Changes in ocular development and levels of transgene expression were examined. The mice with the highest levels of BMP7 expression showed extensive apoptosis throughout the neural retina beginning shortly after the onset of transgene expression. This led to rapid, prenatal degeneration of the neural retina, followed by progressive posteriorization of the zone of differentiation in the lens. In order to test whether the delay in fiber cell induction was due to loss of the ability of the lens cells to respond to extracellular inductive signals, the BMP7 mice were mated to mice expressing fibroblast growth factor 3 (FGF3) in the lens. FGF family members are effective Vision Research 42 (2002) [427] [428] [429] [430] [431] [432] [433] [434] [435] [436] [437] [438] www.elsevier.com/locate/visres at inducing lens fiber differentiation in explant culture systems as well as in transgenic mice (McAvoy, Chamberlain, de Iongh, Richardson, & Lovicu, 1991; Robinson et al., 1995a; Lovicu & Overbeek, 1998) . FGF3 was not able to rescue or inhibit the retinal degeneration, but it did induce fiber cell differentiation even in the presence of BMP7.
Methods

DNA constructs
Human BMP7 cDNA plasmid pcBMP7 (obtained from Dr. G. Karsenty, Baylor College of Medicine) was cut with HindIII and XbaI releasing the cDNA fragment plus flanking 5 0 and the 3 0 b globin noncoding sequences. This fragment was first inserted into pUC19, then reisolated as a HindIII/XmaI fragment that was ligated to a HindIII/XmaI digest of the aA-crystallin promoter vector 2 (CPV2) (Reneker, Silversides, Patel, & Overbeek, 1995) to make the CPV2-hBMP7 construct. The cDNA is inserted between the promoter and the splicing/polyadenylation signals from the early region of SV40 virus (Fig. 1 ).
Generation of transgenic mice
The CPV2-hBMP7 construct was digested with NotI, bands were separated by agarose gel electrophoresis, and the microinjection fragment was cut out and purified using a QiaexII gel extraction kit (Qiagen, Hilden, Germany). The injection fragment (2.8 kb) was eluted in 10 mM tris-HCl, pH 7.4, 0.1 mM EDTA and diluted to a final concentration of 2 ng/ll. The pronuclei of single cell stage FVB/N embryos were microinjected as described (Taketo et al., 1991) . Transgenic mice were identified by polymerase chain reaction (PCR) using a protocol provided by Dr. Gary Truett. Tails were boiled in 25 mM NaOH/0.2 mM EDTA for 20 min to release the genomic DNA into solution, then neutralized in 40 mM tris-HCl, pH 5 (Truett et al., 2000) . SV40 sense and antisense primers were used for the PCR amplifications (Lovicu & Overbeek, 1998) .
Histology
Female FVB/N mice (5-6 weeks old) were superovulated and mated to transgenic or nontransgenic males to establish timed pregnancies. Embryos were delivered by Caesarean sections and were screened by PCR (see above). Embryonic heads (or postnatal eyes) were fixed in 10% phosphate buffered formalin for one to two days with shaking at room temperature. The tissues were then transferred to 70% ethanol, dehydrated, paraffin embedded, and 5 lm thick sections were cut. Histochemical staining was done using haematoxylin and eosin.
In situ hybridization
Transcripts containing SV40, BMP7, Msx2, Id1, or p57 sequences were detected using [
35 S] UTP labeled riboprobes as described previously (Robinson et al., 1995a) . The 0.3 kb SV40 probe was synthesized using EcoRI digestion and T3 RNA polymerase (Promega) for the antisense probe and HindIII digestion plus T7 RNA polymerase (Promega) for the sense probe. The antisense and sense probes for mouse BMP7 were generated from plasmid BMP7-73 (Genetics Institute). A fragment of the mouse Msx2 cDNA (provided by Dr. R. Maas) was cloned into Bluescript KS. An antisense probe was made following BamHI digestion and transcription using the T7 promoter. Id1 cDNA was obtained via reverse transcriptase (RT)-PCR from 3 week Fig. 1 . Microinjection construct. Schematic drawing of the CPV2-BMP7 construct. A human BMP7 cDNA (hBMP7) of about $1.5 kb flanked by b-globin non-translated sequences was subcloned into the CPV2 plasmid, between the aA-crystallin promoter (aAp; Reneker et al., 1995) and SV40 sequences containing an intron and a polyadenylation (pA) sequence from small t antigen. Primers SV40A and SV40B, which flank the intron were used to screen genomic tail DNA via PCR. The SV40 sequence was used to generate a riboprobe for in situ hybridization.
old mouse eyes using the sense oligo 5 0 -CCGGAA-TTCTGCAGCTGGAGCTGAACTC-3 0 and the antisense oligo 5 0 -CGCTCTAGAGAAGGGCTGGAGTC-CATCTG-3 0 . The PCR product ($190 bp) was cloned into Bluescript KS and used to make an antisense probe capable of detecting both Id1a and Id1b transcripts. An antisense p57 riboprobe was made using a mouse p57 cDNA plasmid provided by Dr. S. Elledge (Baylor College of Medicine). Hybridizations were done on 5 lm thick ocular sections and were exposed to photographic emulsion for 6-10 days before developing and haematoxylin counterstaining. In some cases, the images were manipulated in Adobe Photoshop so that the silver grains seen under dark-field illumination are pseudocolored red and combined with the corresponding bright-field images.
Apoptosis
Terminal transferase-mediated dUTP nick-end labeling (TUNEL) was used to detect DNA fragmentation associated with apoptosis. Samples were treated with 40 lg/ml of Proteinase K for 15 min at room temperature, quenched in methanol/hydrogen peroxide and labeled with 1 nmol of biotin-16-dUTP (Boehringer Mannheim) using 50 U of terminal deoxynucleotidyl transferase (Gibco). Detection of biotin labeled tissue was via the ABC and 3,3 0 -diaminiobenzidine (DAB) methods mentioned below. The sections were counterstained briefly with methyl green.
Immunohistochemistry
An antibody against human BMP7 was used for immunohistochemistry. Sections through embryonic and postnatal eyes were first blocked with 10% normal horse serum in PBS for 1 h to decrease nonspecific antibody interactions. This same solution was used to dilute the antibodies. Endogenous peroxidase activity was blocked using 3% H 2 O 2 in 10% methanol. Monoclonal hBMP7 antibody (Genetics Institute h1b5/1.8.5) was used at a dilution of 1:200. After rinsing in phosphate buffer saline (PBS), biotinylated anti-mouse IgG antibody was applied. Detection was via incubation with avidinDH, biotinylated horseradish peroxidase reagent (Vectastain ABC kit, Vector Laboratories) and DAB to give a brown stain.
To identify cells in S-phase, 100 lg/g of body weight of 5-bromo-2 0 -deoxyuridine (BrdU) was injected intraperitoneally in postnatal or pregnant mice along with 10 lg/g of body weight of 5-fluoro-2 0 -deoxyuridine (to inhibit endogenous thymidine synthesis) in PBS as previously described (Fromm, Shawlot, Gunning, Butel, & Overbeek, 1994) . 1-2 h following injection, tissues were harvested, fixed in 10% formalin, dehydrated, and embedded in paraffin. 5 lm sections were cut, and endogenous peroxidase activity was blocked as indicated above. The sections were next digested with 0.02% pepsin for 20 min at 37°C, then treated with 2 N HCl. After neutralization using 0.1 M sodium borate, pH 8.5, the slides were incubated in PBS supplemented with normal horse serum. Monoclonal anti-BrdU antibody (Dako, Carpinteria, CA) was applied at 1:60 followed by biotinylated antibody against mouse-IgG (Vector Laboratories, Inc.). Avidin-biotinHRP complex was applied using the Vectastain ABC kit as mentioned above, and detected using DAB.
Generating double transgenic mice
Double transgenic mice were generated by mating CPV2-FGF3 mice (family OVE391A) (Robinson et al., 1998) to CPV2-BMP7 mice (family OVE1340A). The BMP7 transgene was detected by PCR amplification using a sense primer toward the 3 0 end of the human BMP7 cDNA, 5 0 -CGGGCCTGTGGCTGCCACTAG-3 0 , and an antisense SV40 primer (SV40B, see Fig. 1 ) to give a $0.6 kb band. PCR amplification was done for 35 cycles under the following conditions: denaturation 30 s at 94°C, annealing 45 s at 58°C, and extension for 2 min at 72°C. A final 10-min extension was done at 72°C
. The FGF3 transgene was detected by PCR amplification using sense primer CR2 and antisense primer F4 (Robinson et al., 1998) . These primers span a portion of the aA-crystallin promoter and the FGF-3 gene respectively, giving a $340 bp band.
Results
Endogenous BMP7 expression
Previous studies on BMP7 knockout mice showed that BMP7 is variably required for lens induction (Dudley et al., 1995; Luo et al., 1995; Wawersik et al., 1999) . However, these studies did not provide information about possible later roles for BMP7, so we used in situ hybridizations to assess the pattern of BMP7 expression in the eye at embryonic day 12.5 (E12.5), E15.5, and postnatal day 1 (P1). In E12.5 and E15.5 eyes, expression was detected in the perioptic mesenchyme, retinal pigmented epithelium (RPE), presumptive cornea, epithelial cells of the lens, and anterior margins of the retina ( Fig. 2A and B) . At E12.5, the hyaloid vasculature also expressed BMP7 ( Fig. 2A) . By P1, expression was most prominent in the developing ciliary body, iris, and lens epithelial cells, but had disappeared from the RPE (Fig. 2C ). Antisense probes for BMP receptors IA and II revealed that expression of these receptors is ubiquitous in the eye from E11.5 to P1 (data not shown).
Generation of transgenic mice
To alter the pattern of BMP7 expression in the eye, transgenic mice expressing the human BMP7 cDNA driven by the lens-specific aA-crystallin promoter were generated. This promoter has been shown to target transgene expression to the lens fiber cells (Reneker et al., 1995; Robinson et al., 1995a) . Potential founder mice were screened by PCR using SV40 primers (SV40A, SV40B) ( Fig. 1) . Eight transgenic founder mice were identified and used to establish families OVE1257, 1258, 1340A, 1340B, 1342A, 1342B, 1343, 1344, and 1345 by matings to nontransgenic FVB/N partners. The families with the most severe ocular changes were OVE1340A, 1342A, and 1343 which all showed dramatic retinal ablation by E15.5 (Table 1 ; Fig. 3B ). Transgenic mice in families OVE1342B and 1344 became microphthalmic in the homozygous state, indicating a gene dosage effect (data not shown). Transgenic mice in families OVE1258 and 1345 showed no apparent ocular defects (see Table 1 ), and mice in family OVE1257 developed cataracts as adults (data not shown). Mice expressing human BMP2 (OVE1202A, 1203) or human BMP4 (OVE1173, 1174) were made in a similar manner, but none showed any obvious ocular defects except for adult cataracts (data not shown).
Transgene expression
To assess transgene expression, in situ hybridizations were performed using an 35 S-labelled SV40 riboprobe (indicated in Fig. 1 ). Transgenic transcripts were detected only in the fiber cells of the lens (Fig. 3A-H) , consistent with previous transgenic studies using the same promoter (Reneker et al., 1995; Robinson et al., 1995a) . The levels of transgene expression corresponded with the severity of the phenotypes (Table 1; Fig. 3 ). Families OVE1340A and 1340B showed the highest levels of expression in conjunction with retinal ablation by E15.5 (Fig. 3A-D) . Families OVE1342B and 1258 showed modest or low transgene expression and later onset of ocular changes ( Fig. 3E-H) . Transgene expression in family OVE1340A at E15.5 was compared to endogenous BMP7 expression using an antisense mouse BMP7 riboprobe that also cross-hybridizes to the transgenic human transcript. Transgene expression in the lens fiber cells was considerably higher than the endogenous ocular expression of BMP7 (compare Fig. 3I and J) .
A monoclonal antibody against human BMP7 was used to assess whether transgenic BMP7 protein was being synthesized in the mouse lens. Transgenic mouse lens fiber cells stained positive for the human BMP7 protein compared to undetectable staining in the control (Fig. 3K and L). The intensity of lens staining increased in accordance with the severity of the phenotype (data not shown). The staining was strongest in the lens and was less apparent in the surrounding ocular space (Fig. 3K) .
To gather more evidence for BMP7 activity outside the lens, we assayed for changes in expression of Msx1, Msx2, Id1, and L1 (Marazzi, Wang, & Sassoon, 1997; Hollnagel, Oehlmann, Heymer, Ruther, & Nordheim, 1999 ; Perides, Safran, Downing, & Charness, 1994), 
Transgene expression was assayed by in situ hybridization. Symbols: þ=À, very weak expression; þþ, moderate expression; þ þ þ, strong expression.
genes known to be downstream targets of BMP signaling in other systems. Antisense probes for each were used for in situ hybridizations on family OVE1340A. At E13.5, the transgenic cornea, neural retina, and lens epithelium showed an increase in Msx2 transcripts relative to the nontransgenic control ( Fig. 4A and B) . Msx1 expression remained unchanged at the same age (data not shown). Id1 transcripts also appeared to be upregulated in the transgenic retina and lens at E13.5 ( Fig. 4C and D) . The apparent increase in expression in the retina may reflect preferential survival of Id1 expressing retinoblasts, rather than an actual elevation in the levels of transcription per cell. Transcripts of L1, a neural cell adhesion molecule upregulated in response to BMPs (Perides et al., 1994) , were also enhanced in OVE1340A eyes at E15.5 (data not shown). The changes in Msx2, Id1, and L1 expression indicate that multiple cell types in the eye respond to BMP signaling and that the transgenic BMP7 protein is being secreted at biologically active levels.
Retinal apoptosis
The most dramatic phenotype in the transgenic eyes was the neurodegeneration in the embyronic retina. Condensed and fragmented nuclei were seen in the retinas of family OVE1340A as early as E13.5 ( Fig. 5A and  C) . Morphological signs of apoptosis were not detected at this age in nontransgenic eyes ( Fig. 5B and D) . To assay for cell death at the molecular level, TUNEL assays were performed. TUNEL positive cells (stained brown) were prevalent in transgenic retinas at E13.5 ( Fig. 5E and G ), but were not seen in the nontransgenic control eyes (Fig. 5F and H) . Since the aA-crystallin promoter first becomes active around E11.5 (Lovicu & Overbeek, 1998) , these results indicate that the retinoblasts respond quickly to the transgene, suggesting that the BMP7 may be directly, rather than indirectly, inducing the apoptosis.
Lens epithelial cell posteriorization correlates with retinal ablation
To analyze other morphological changes, a time course of the ocular changes in family OVE1340A was established ( Fig. 6) . At E12.5, transgene expression was present in the lens fiber cells (data not shown), but the retinal histology was essentially normal (Fig. 6A) . By E15.5, the neural retina was almost entirely ablated, leaving only a few disorganized cells in the posterior of the eye (Fig. 6C) . By E17.5, the position of the transition zone (where lens epithelial cells are induced to become fiber cells) had begun to move posteriorly (Fig. 6E, arrowheads) . By P1, lens epithelial cells surrounded the entire lens (see Fig. 7) . Family OVE1340B at P1 shows a less complete retinal degeneration (Fig. 6G) . In this family, the transition zone remained at equatorial region (Fig. 6G, arrowheads) suggesting that the partially ablated retina continues to contribute lens differentiation signals. 35 S-labelled SV40 riboprobe. Dark-field microscopy for families: (A) OVE1340A, (C) 1340B, (E) 1342B, and (G) 1258 shows that transgene expression is fiber cell specific at E15.5. The corresponding bright-field images show the extensive retinal degeneration in: (B) OVE1340A and (D) 1340B but not (F) 1342B or (H) 1258. BMP7 expression was also assayed using an 35 S-labelled antisense mouse BMP7 probe hybridized to: (I) OVE1340A and (J) nontransgenic eyes at E15.5. The probe detects both the endogenous mouse BMP7 and the transgenic human BMP7 transcripts. The transgenic transcript is present at a significantly higher level than the endogenous transcript in the lens. Immunohistochemical staining using a human BMP7 antibody shows staining at E14.5 in the lens fiber cells of OVE1340A eyes (K) while the nontransgenic eye at E14.5 reveals no staining (L); scale bar 100 lm. Abbreviation: e, lens epithelial cells; f, lens fiber cells; l, lens; r, retina.
Molecular evidence for changes in the lens
To confirm that lens differentiation is affected in the CPV2-BMP7 transgenic mice, markers for lens differentiation were examined. The region of transcription of the cyclin-dependent kinase inhibitor p57, a marker for the onset of fiber cell differentiation (Zhang, Wong, DePinho, Harper, & Elledge, 1998) , was clearly posteriorized in the transgenic mice at E17.5 (Fig. 7A , arrowheads) and P1 (Fig. 7C arrowheads) . The region of p57 upregulation remains at the equatorial zone in nontransgenic eyes (Fig. 7B and D) . The fact that p57 expression is still upregulated at the posterior of the transgenic lenses suggests that the lens differentiation signals persist for a few days after retinal ablation. Immunohistochemical assays for b-crystallin, a marker for lens fiber cells, also showed an invasion of lens epithelial cells posteriorly (data not shown), supporting the idea that the bow region moves posteriorly and that there is a gradual loss of lens differentiation.
BrdU assays for cell proliferation were done using E13.5, E15.5, E17.5, and P1 eyes from OVE1340A and nontransgenic mice. BrdU-positive epithelial cells were found anterior and posterior to the equator in transgenic E17.5 and P1 sections ( Fig. 7E and G, arrowheads). In comparison, BrdU stained epithelial cells exist only in the anterior half of the lens for the nontransgenic controls ( Fig. 7F and H) . In both sets of lenses, only the epithelial cells and not the fiber cells incorporated BrdU. In the transgenic mice, there appears to be a decrease in proliferation of lens epithelial cells. At E13. The decrease in epithelial cell proliferation in combina- Fig. 4 . In situ hybridizations using probes for Msx2 and Id1. Antisense 35 S-labelled Msx2 was hybridized to: (A) a nontransgenic and (B) a transgenic OVE1340A E13.5 eye. Msx2 is normally weakly expressed in the cornea, lens, and anterior retina of nontransgenic eyes (A). In comparison, Msx2 expression was upregulated in the lens epithelial cells, cornea, and neural retina of the transgenic eye (B). Id1 expression was also assessed by in situ hybridization to: (C) a nontransgenic and (D) a transgenic OVE1340A E13.5 eye. Id1 is expressed in the retina and the cornea of the nontransgenic eye. In the transgenic eye, the Id hybridization signal was elevated in the neural retina, the RPE, and throughout the lens, scale bar 100 lm.
tion with the absence of new fiber cells may explain the slowed growth of the transgenic lenses.
FGF still induces lens differentiation in CPV2-BMP7 mice
To assess whether the lens epithelial cells in family OVE1340A can still differentiate in response to a differentiation signal, the mice were crossed to CPV2-FGF3 mice from family OVE391A. In the OVE391A mice, expression of FGF3 in the lens induces premature lens fiber cell differentiation (Robinson et al., 1998) . At E15.5, mice with CPV2-FGF3 alone and the CPV2-FGF3/CPV2-BMP7 double transgenic mice showed fiber cell induction throughout the lens (Fig. 8A and B) . By E18.5, epithelial cell differentiation is widespread in both sets of transgenic mice with some lenses showing complete epithelial cell differentiation into fiber cells (Fig. 8C and D) . The retinas in the BMP7 transgenic mice were largely ablated at both ages, indicating that FGF-3 expression does not interfere with the effects of BMP7 on the retina. The results also indicate that the BMP7 expression in the lens does not incapacitate the ability of the lens cells to respond to a differentiation signal.
Discussion
The CPV2-BMP7 transgenic mice provide a novel model system for studies of prenatal retinal degeneration. In the transgenic mice, the levels of transgene expression (assayed by in situ hybridization and by immunostaining) correlate with the severity of the retinal ablation. The temporal appearance of retinal apoptosis also correlates with that of transgene expression. Since more than one family shows this phenotype, the retinal cell death is clearly due to expression of the BMP7 transgene, rather than the effect of an insertional mutation at the transgenic integration site. The phenotype is accompanied by an increase in Msx2, Id1, and L1 transcripts (all known to be upregulated by exogenously applied BMP proteins) in multiple ocular tissues, suggesting that the transgenic BMP7 protein is active and secreted. We also generated analogous CPV2-BMP2 and CPV2-BMP4 families of mice, but none of these mice showed retinal defects (data not shown), suggesting that the neuronal cell death is specifically induced by BMP7. Differential responses to different BMPs were previously described in explants of mouse forebrain neuroectoderm where BMP2 or BMP4 were more potent in inducing cell death and Msx1 expression than BMP7 (Furuta, Piston, & Hogan, 1997). Other cases in which BMPs have been shown to cause apoptosis include the interdigital cells of the limb buds (Zou & Niswander, 1996) , neural crest cells of rhombomeres 3 and 5 (Graham, Francis-West, Brickell, & Lumsden, 1994) , and P19 cells (Marazzi et al., 1997) .
In the most severely affected BMP7 transgenic families, the retina begins apoptosis soon after the onset of transgene expression (Fig. 6A) . The death causes a thinning of the retina, nuclear condensation, and DNA fragmentation. The process occurs so quickly that only a small fraction of the neural retina remains at E15.5, and by P1 the neural retina has disappeared.
Many neurons undergo apoptosis upon p53 activation in response to DNA fragmentation or inappropriate cell cycle entry (Hughes, Alexi, & Schreiber, 1997). Fig. 6 . Time course of retinal ablation and posterior movement of the lens differentiation zone. Hematoxylin and eosin stained sections for family OVE1340A at (A) E12.5, (C) E15.5, and (E) E17.5 were compared to sections from nontransgenic embryos at the same ages (B,D,F). At E15.5, the transgenic mouse neural retina is almost fully degenerated (C), but the transition zone between lens epithelial and lens fiber cells (arrowheads) has not yet moved posteriorly. At E17.5 the transition zone has begun to move posteriorly (E, arrowheads) and the transgenic lens is significantly smaller. In family OVE1340B at P1, the transition zone (arrowheads) has not posteriorized, even though the neural retina has started to degenerate (G), scale bar 100 lm (A)-(F); 200 lm (G). Abbreviation: r, retina.
In the OVE1340A mice neither levels of p53 nor p21, a CDK inhibitor known to be upregulated by active p53 (Harper & Elledge, 1996) were increased, suggesting that p53 is not involved in the apoptosis (data not shown). In situ hybridizations for Bcl-xL, a Bcl2 homologue that protects against apoptosis (Boise et al., 1993) , and for Bax and Bad, two homologues that cause apoptosis (Oltvai, Milliman, & Korsmeyer, 1993; Yang et al., 1995) did not reveal significant changes in the transgenic neural retina, indicating that these genes are not the culprits for the apoptosis (data not shown). One possible explanation is that the BMP-induced upregulation of Msx2 or Id is causing the apoptosis, since upregulation of either one of these genes has been shown to cause apoptosis in other cell types (Takahashi et al., 1998; Norton & Atherton, 1998; Tanaka et al., 1998) .
At the moment we have not defined the molecular basis for the BMP7-induced neuronal apoptosis, and therefore multiple different mechanisms warrant consideration. One possibility is inappropriate expression and/or stimulation of the p75 subunit of the nerve growth factor receptor (Frade, Rodriguez-Tebar, & Barde, 1996) . Another possibility is that an increase in intracellular Ca 2þ could lead to apoptosis by the activation of calpain, calmodulin, and/or calcineurin (McConkey, 1996) . Another possibility is that DNA ligase IV and/or XRCC4 are rendered nonfunctional (Chun & Schatz, 1999 ) so that if DNA rearrangements Fig. 7 . p57 and BrdU changes. Transgenic OVE1340A (A,C) and non-transgenic (B,D) mouse eye sections were analyzed by in situ hybridization for p57 expression. While p57 expression is induced upon fiber cell initiation at the equatorial region of nontransgenic lenses at E17.5 (B, arrowheads) and P1 (D), the onset of p57 expression is moved posteriorly in the transgenic lenses at E17.5 (A, arrowheads) and P1 (C, arrowheads). BrdU incorporation (brown staining), which indicates cells in S phase, was also assayed (E)-(H). There is a general decrease in the proliferation of lens epithelial cells in the transgenic family (E,G) compared to the nontransgenic mice (F,H). At E17.5 (E) and P1 (G) the arrowheads indicate proliferating epithelial cells in the posterior part of the transgenic lens, scale bar 100 lm (A-C, E-H); 200 lm (D).
occur as a part of retinal development, apoptosis may occur due to the inability to repair these breaks. Caspases may also play a part in this apoptosis. At the moment it seems unlikely that the apoptosis is due to the lack of appropriate neurotrophic factor stimulation, since the retinal apoptosis begins when the neuronal cells are still immature and presumably do not yet require neurotrophic factors for survival.
Despite the retinal ablation by E15.5 in OVE1340A mice, it is not until E17.5 that the bow region of the lens begins to move posteriorly. It may be that the lens receives a lingering differentiation signal synthesized earlier by the retina or produced by the small patch of remaining retina. In frogs a similar lens epithelial cell posteriorization did not occur until a few days after retina removal (Sokolova et al., 1970) . In addition, the lens differentiation signal may have an extended life span in the heparin sulfate rich environment of the vitreous (Tsen, Halfter, Kroger, & Cole, 1995) . For example, FGFs are known to be able to induce fiber cell differentiation (McAvoy et al., 1991) and to be stabilized by binding to heparin sulfate (Klagsbrun, 1992) . The patterns of p57 and b-crystallin expression suggest the gradual disappearance of the signal for fiber cell differentiation subsequent to neural retinal ablation. By P1 the disappearance of the retina is accompanied by the complete enclosure of the lens by lens epithelial cells.
The changes in Msx2 and Id1 transcription in the transgenic lenses (Fig. 4) show that BMP7 can directly alter gene expression in the lens. However, since expression of FGF3 can induce these lens cells to undergo fiber cell differentiation, BMP7 expression does not incapacitate the ability of the lens cells to differentiate. In addition, if BMP7 were directly responsible for inhibiting fiber cell differentiation, we would predict that p57 induction would be completely lost in the transgenic lenses, rather than being slowly displaced toward the posterior of the lens. The notion that the effect on the lens is indirect is consistent with earlier studies (Coulombre & Coulombre, 1963; Yamamoto, 1976 ) that showed that surgical rotation of the lens resulted in the loss of fiber cell differentiation on the side of the lens facing away from the retina and differentiation of the lens epithelium to lens fiber cells on the side facing the retina. Nonetheless, at this point in time, we have not established whether the loss of fiber cell differentiation is due to direct inhibition by BMP or is a consequence of the retinal apoptosis.
At P1 the transgenic lens is appreciably smaller than a normal lens. One explanation for the decreased lens epithelial cell proliferation may be that the synthesis of proliferation signals such as PDGF-A and PDGF-B may be reduced or shut off. Since these two growth factors are expressed from the ciliary body and iris (Reneker & Overbeek, 1996) , improper development of these ocular tissues in the CPV2-BMP7 mice may cause a reduction in synthesis of these signals. It is also possible that a reduction in the number of fiber cells may cause reduced epithelial cell proliferation. In transgenic lenses overexpressing a dominant negative FGF receptor, fiber cell numbers are reduced by apoptotic death and there is a concurrent decrease in lens epithelial cell proliferation (Robinson, MacMillan-Crow, Thompson, & Overbeek, 1995b) .
The FGF3/BMP7 double transgenic allowed us to assay in vivo for synergistic and/or antagonistic interactions between two different, developmentally important families of growth factors. FGFs are known to stimulate FGF receptors, which are tyrosine kinases that can signal through the ras-raf-MAPK pathway (Marshall, 1995) . In contrast, BMP receptors are serinethreonine kinases that activate Smad1 and Smad5 transcription factors (Kretzschmar & Massague, 1998) . Previous studies have suggested that FGF and BMP effects on a tissue might be antagonistic. BMPs have been shown to antagonize the downstream expression of genes upregulated by FGFs in tooth formation (Neubuser, Peters, Balling, & Martin, 1997) , maxillary primordia (Barlow, Bogardi, Ladher, & Francis-West, 1999) , and in endochondral hypertrophic chondrocytes (Terkeltaub et al., 1998) . On the other hand, FGFs have been shown to antagonize the effects of BMPs in the interdigital membrane (Ganan, Macias, DuterqueCoquillaud, Ros, & Hurle, 1996) and the limb bud (Niswander & Martin, 1993) . The fact that FGF3/BMP7 double transgenic lenses showed differentiation of all lens epithelial cells to fiber cells indicates that the FGF3 signal is not, or is only partially, antagonized by BMP7 in the lens. Additionally, the retinal ablation caused by an excess of BMP7 was not rescued by the FGF3 signal. However, BMP7 seemed to partially rescue the disruption in the corneal morphology caused by FGF3 expression ( Fig. 8A and B) . The mechanisms for these tissue-specific differences are undefined.
Our study, in combination with the BMP7 knockout studies (Dudley et al., 1995; Luo et al., 1995; Wawersik et al., 1999) , suggests that the level of BMP7 expression must fall within a defined range for ocular development to occur normally. Since overexpression of BMP7 rapidly induces retinal apoptosis, the CPV2-BMP7 transgenic mice provide a new system for studies of programmed cell death during neuronal development and for analysis of ocular development after prenatal ablation of the neural retina. In the future, it will also be important to determine whether postnatal upregulation of BMP7 can cause retinal degeneration.
